These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
166 related articles for article (PubMed ID: 11544014)
1. Immunotherapy for rheumatoid arthritis. Taylor PC; Williams RO; Maini RN Curr Opin Immunol; 2001 Oct; 13(5):611-6. PubMed ID: 11544014 [TBL] [Abstract][Full Text] [Related]
2. Anti-TNFalpha therapy for rheumatoid arthritis: an update. Taylor PC Intern Med; 2003 Jan; 42(1):15-20. PubMed ID: 12583612 [TBL] [Abstract][Full Text] [Related]
3. Anti-tumor necrosis factor therapies. Taylor PC Curr Opin Rheumatol; 2001 May; 13(3):164-9. PubMed ID: 11333343 [TBL] [Abstract][Full Text] [Related]
4. Immunological therapies for rheumatoid arthritis. Edwards CJ Br Med Bull; 2005; 73-74():71-82. PubMed ID: 16174791 [TBL] [Abstract][Full Text] [Related]
5. Current immunotherapy in rheumatoid arthritis. Meier FM; Frerix M; Hermann W; Müller-Ladner U Immunotherapy; 2013 Sep; 5(9):955-74. PubMed ID: 23998731 [TBL] [Abstract][Full Text] [Related]
6. Pursuit of optimal outcomes in rheumatoid arthritis. Scott DL Pharmacoeconomics; 2004; 22(2 Suppl 1):13-26. PubMed ID: 15157001 [TBL] [Abstract][Full Text] [Related]
7. Anti-TNF therapy for rheumatoid arthritis and other inflammatory diseases. Taylor PC Mol Biotechnol; 2001 Oct; 19(2):153-68. PubMed ID: 11725485 [TBL] [Abstract][Full Text] [Related]
8. The role and therapeutic targeting of IL-6 in rheumatoid arthritis. Narazaki M; Tanaka T; Kishimoto T Expert Rev Clin Immunol; 2017 Jun; 13(6):535-551. PubMed ID: 28494214 [TBL] [Abstract][Full Text] [Related]
9. Efficacy and safety of certolizumab pegol in rheumatoid arthritis: meeting rheumatologists' requirements in routine clinical practice. Punzi L; Lapadula G; Mathieu A BioDrugs; 2014 Apr; 28 Suppl 1():S25-37. PubMed ID: 24687236 [TBL] [Abstract][Full Text] [Related]
10. Specific therapy to regulate inflammation in rheumatoid arthritis: molecular aspects. García-Hernández MH; González-Amaro R; Portales-Pérez DP Immunotherapy; 2014; 6(5):623-36. PubMed ID: 24896630 [TBL] [Abstract][Full Text] [Related]
11. Regulation of TNF-α with a focus on rheumatoid arthritis. Moelants EA; Mortier A; Van Damme J; Proost P Immunol Cell Biol; 2013 Jul; 91(6):393-401. PubMed ID: 23628802 [TBL] [Abstract][Full Text] [Related]
12. Tocilizumab, a humanized anti-IL-6R antibody, as an emerging therapeutic option for rheumatoid arthritis: molecular and cellular mechanistic insights. Hashizume M; Tan SL; Takano J; Ohsawa K; Hasada I; Hanasaki A; Ito I; Mihara M; Nishida K Int Rev Immunol; 2015 May; 34(3):265-79. PubMed ID: 25099958 [TBL] [Abstract][Full Text] [Related]
13. Biological therapies: a novel approach to the treatment of autoimmune disease. Fox DA Am J Med; 1995 Jul; 99(1):82-8. PubMed ID: 7598148 [TBL] [Abstract][Full Text] [Related]
14. Anti-TNF alpha therapy of rheumatoid arthritis: what have we learned? Feldmann M; Maini RN Annu Rev Immunol; 2001; 19():163-96. PubMed ID: 11244034 [TBL] [Abstract][Full Text] [Related]
15. Tocilizumab in the treatment of adult rheumatoid arthritis. Sanmartí R; Ruiz-Esquide V; Bastida C; Soy D Immunotherapy; 2018 Mar; 10(6):447-464. PubMed ID: 29495891 [TBL] [Abstract][Full Text] [Related]
19. Databases of patients with early rheumatoid arthritis in the USA. Sokka T; Willoughby J; Yazici Y; Pincus T Clin Exp Rheumatol; 2003; 21(5 Suppl 31):S146-53. PubMed ID: 14969067 [TBL] [Abstract][Full Text] [Related]
20. [Gene transfer immunotherapy in rheumatoid arthritis: perspectives]. Jorgensen C Rev Med Interne; 2001 Feb; 22(2):163-71. PubMed ID: 11234674 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]